BEDMINSTER, N.J.--(BUSINESS WIRE)--NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, is joining the National Organization for Rare Disorders (NORD) and other organizations around the world today to observe World Rare Disease Day on February 29, 2012. This observance spotlights the nearly 30 million people in the United States and millions more worldwide who are living with a rare disorder, many of whom have difficulty getting the right care because of a lack of education about these conditions.
